Effectiveness of Zonal Observation in Reducing Restrictive Practices on a Male Psychiatric Intensive Care Unit (PICU) Over a One-Year Period
Yetunde Arowora, Faizaan Syed, Shantala Satisha

TL;DR
Zonal observation reduced restrictive practices in a male psychiatric unit without compromising safety over a year.
Contribution
Introducing zonal observation as a less restrictive alternative to 1:1 and 2:1 observations in a PICU.
Findings
Enhanced observation duration dropped from 51 to 22 days in the first 2 months and remained low after 10 months.
Seclusion episodes initially increased but decreased after 10 months, with shorter average durations.
No increase in violence or aggression was observed, and patient and staff experiences improved.
Abstract
Aims: We aimed to reduce the use of seclusion, 1:1 and 2:1 observations in our PICU, without compromising safety, by introducing zonal observation levels which is considered less intrusive, allowing greater privacy for the patient and better engagement. Hypothesis: We expect a reduction in number of enhanced observations with no change in levels of aggression with a further reduction in the second survey as staff become more confident in using zonal observations. Background: PICUs often rely on enhanced observations, such as 1:1 or 2:1, to reduce violence and aggression. However, these practices have limited evidence of effectiveness and are frequently perceived negatively by staff and patients. At Willow Suite, a 12-bed male PICU, zonal observations were introduced in January 2024 as a less restrictive alternative. This approach involved designating staff to specific zones for…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealthcare Decision-Making and Restraints · Emergency and Acute Care Studies · Palliative Care and End-of-Life Issues
